Labtician Ophthalmics  

Glaucoma

Glaucoma

The glaucoma treatment algorithm has benefited from exciting advances in recent years. The consequent technologies have provided valuable new treatment options for patients living with this destructive disease.

Labtician Ophthalmics, Inc., continues to be a trailblazer in this therapeutic area, having introduced several leading-edge tools for glaucoma management in Canada, including:

  • Ahmed™ Glaucoma Valve (AGV™), featuring a unique, non-obstructive valve system to control intraocular pressure (IOP) for patients with refractory glaucoma or who are at high risk of trabeculectomy failure
  • iStent® Trabecular Micro-Bypass, a micro invasive glaucoma surgery device that creates a permanent opening in the trabecular meshwork. Safely implanted during cataract surgery, it offers mild-to-moderate open angle glaucoma patients the chance to forego medicated drops
  • Sensimed Triggerfish® Sensor, a breakthrough non-invasive, continuous IOP monitoring system. It employs a soft, hydrophilic, single-use contact lens that the patient wears for up to 24 hours during normal activities. The lens features embedded passive and active strain gauges to monitor fluctuations in diameter of the corneoscleral junction, which are wirelessly recorded and the data transferred to the ophthalmologist’s computer via Bluetooth technology.
Labtician’s offering carries over into providing a full range of essential accessories, including knives and blades, electrosurgery devices, and instrumentation.